Ebang International
EBON
Mawson Infrastructure
MIGI
Intchains Group
ICG
BTCS Inc
BTCS
Bakkt Holdings
BKKT
US Stock MarketDetailed Quotes
BGLC BioNexus Gene Lab
- 0.258
- -0.002-0.69%
Trading Dec 19 13:38 ET
4.64MMarket Cap21.52P/E (TTM)
0.270High0.253Low19.79KVolume0.260Open0.260Pre Close5.09KTurnover0.14%Turnover RatioLossP/E (Static)17.97MShares3.39052wk High0.49P/B3.56MFloat Cap0.23152wk Low--Dividend TTM13.78MShs Float9.490Historical High--Div YieldTTM6.73%Amplitude0.231Historical Low0.257Avg Price1Lot Size
BioNexus Gene Lab Key Stats
EPS
According to the latest financial report of BioNexus Gene Lab, the latest earnings per share (TTM) for the company is -0.07. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about BioNexus Gene Lab's free cash flow? The latest report shows it as -1.66M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BioNexus Gene Lab shows that the company's current ratio is 4.98, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BioNexus Gene Lab, the quick ratio is 3.99, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of BioNexus Gene Lab? The latest ROE figure is -14.21%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BioNexus Gene Lab, the total asset return on investment (ROA) is -12.16%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BioNexus Gene Lab's latest financial report to see how their gross margin is doing - currently at 12.41%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BioNexus Gene Lab, the net profit margin is -51.15%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.